S. Lintula

发表

Technique for strand-specific gene-expression analysis and monitoring of primer-independent cDNA synthesis in reverse transcription.

C. Haglund, U. Stenman, A. Paju, 2012, BioTechniques.

Quantitative detection of low-copy-number mRNAs differing at single nucleotide positions.

A. Palotie, P. Finne, A. Orpana, 2003, BioTechniques.

Expression of Vascular Endothelial Growth Factor in Peripheral Blood Cells of Preeclamptic Women

U. Stenman, S. Lintula, E. Halmesmäki, 2003, Hypertension in pregnancy.

The expression of prostate-specific membrane antigen in peripheral blood leukocytes.

U. Stenman, S. Lintula, 1997, The Journal of urology.

Cellular localization of c-jun messenger ribonucleic acid and protein and their relation to the proliferation marker Ki-67 in the human endometrium.

E. Rutanen, P. Heikkilä, S. Lintula, 1998, The Journal of clinical endocrinology and metabolism.

Quantification of prostate specific antigen mRNA levels in circulation after prostatic surgery and endocrine treatment by quantitative reverse transcription‐polymerase chain reaction

U. Stenman, P. Finne, A. Rannikko, 2004, Scandinavian journal of clinical and laboratory investigation.

Detection of squamous‐cell carcinoma antigen‐expressing tumour cells in blood by reverse transcriptase‐polymerase chain reaction in cancer of the uterine cervix

H. Lehväslaiho, U. Stenman, J. Stenman, 1997, International journal of cancer.

Extendable blocking probe in reverse transcription for analysis of RNA variants with superior selectivity

C. Haglund, U. Stenman, V. Olkkonen, 2014, Nucleic acids research.

Detection of messenger RNA for the β‐subunit of chorionic gonadotropin in urinary cells from patients with transitional cell carcinoma of the bladder by reverse transcription‐polymerase chain reaction

U. Stenman, J. Stenman, K. Hotakainen, 1999, International journal of cancer.

Expression of human chorionic gonadotropin beta-subunit type I genes predicts adverse outcome in renal cell carcinoma.

U. Stenman, P. Finne, A. Paju, 2006, The Journal of molecular diagnostics : JMD.

Expression of luteinising hormone and chorionic gonadotropin beta-subunit messenger-RNA and protein in human peripheral blood leukocytes

U. Stenman, H. Alfthan, J. Schröder, 2000, Molecular and Cellular Endocrinology.

Tumor expression of human chorionic gonadotropin beta mRNA and prognosis of prostate cancer treated by radical prostatectomy

U. Stenman, T. Mirtti, A. Rannikko, 2019, Scandinavian journal of clinical and laboratory investigation.

Overexpression of Human Chorionic Gonadotropin β Genes 3, 5 and 8 in Tumor Tissue and Urinary Cells of Bladder Cancer Patients

U. Stenman, A. Paju, J. Stenman, 2006, Tumor Biology.

Developing biomarkers for improved diagnosis and treatment outcome monitoring of bladder cancer

K. Hotakainen, S. Lintula, 2010, Expert opinion on biological therapy.

DETECTION OF PROSTATE SPECIFIC mRNAs IN CIRCULATION AND IN PROSTATIC TISSUE

S. Lintula, 2005 .

Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms

Min Ju Park, T. Visakorpi, H. Nevanlinna, 2016, The Prostate.

Tumor‐associated trypsin inhibitor in normal and malignant renal tissue and in serum of renal‐cell carcinoma patients

U. Stenman, O. Carpén, B. Ljungberg, 1999, International journal of cancer.

MAPK inhibitors induce serine peptidase inhibitor Kazal type 1 (SPINK1) secretion in BRAF V600E‐mutant colorectal adenocarcinoma

C. Haglund, Kati Räsänen, H. Koistinen, 2017, Molecular oncology.

Relative concentrations of hK2/PSA mRNA in benign and malignant prostatic tissue

Stig Nordling, S. Nordling, U. Stenman, 2005, The Prostate.

Prognostic impact of kallikrein‐related peptidase transcript levels in prostate cancer

E. Diamandis, H. Koistinen, U. Stenman, 2023, International journal of cancer.